JP2941880B2 - Emulsified cosmetic - Google Patents
Emulsified cosmeticInfo
- Publication number
- JP2941880B2 JP2941880B2 JP8690090A JP8690090A JP2941880B2 JP 2941880 B2 JP2941880 B2 JP 2941880B2 JP 8690090 A JP8690090 A JP 8690090A JP 8690090 A JP8690090 A JP 8690090A JP 2941880 B2 JP2941880 B2 JP 2941880B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- emulsified cosmetic
- cyclodextrin
- cream
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 14
- 229940060184 oil ingredients Drugs 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 11
- 239000003755 preservative agent Substances 0.000 description 10
- 239000008294 cold cream Substances 0.000 description 9
- -1 fatty acid salts Chemical class 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 101710159621 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase Proteins 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 229940057995 liquid paraffin Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- ZLBTVOAZVODUBE-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol 2-(2-hydroxyethoxy)ethanol prop-1-ene Chemical compound CC=C.OCCOCCO.OCC(CO)(CO)CO ZLBTVOAZVODUBE-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は乳化化粧料、更に詳しくはヒドロキシアルキ
ル化シクロデキストリン(以下、HACDと略す)を乳化剤
として含有し、特に皮膚、毛髪用化粧品として好適に使
用することのできる安定性、安全性に優れた乳化化粧料
に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention contains an emulsified cosmetic, more specifically a hydroxyalkylated cyclodextrin (hereinafter abbreviated as HACD) as an emulsifier, and is particularly suitable as a cosmetic for skin and hair. The present invention relates to an emulsified cosmetic having excellent stability and safety which can be used for cosmetics.
[従来の技術] 従来から、油と水を含有する乳化化粧料においては、
各種の界面活性剤が単独で、もしくは複数組合せて用い
られてきた。しかしながら、例えばアルキル硫酸塩、高
級脂肪酸塩等のイオン性界面活性剤は、これを高濃度で
用いた場合、皮膚刺激の懸念があり、またポリオキシエ
チレン型の非イオン界面活性剤を用いた場合には、パラ
ベン等の防腐剤を不活性化する等、相溶性に問題があっ
た。[Prior art] Conventionally, in an emulsified cosmetic containing oil and water,
Various surfactants have been used alone or in combination. However, for example, ionic surfactants such as alkyl sulfates and higher fatty acid salts may cause skin irritation when used at a high concentration, and when polyoxyethylene type nonionic surfactants are used. Have problems in compatibility, such as inactivating preservatives such as parabens.
[発明が解決しようとする課題] かかる問題を解決するためにシクロデキストリン、あ
るいはその誘導体を用いる技術が開発されている。特開
昭58−58139号公報には、シクロデキストリンを油溶性
界面活性剤と併用し、特定の方法にて乳化する技術が開
示されている。また、特開昭63−194726号公報にはメチ
ル化β−シクロデキストリンを乳化補助剤として用いる
技術が開示されている。[Problem to be Solved by the Invention] In order to solve such a problem, a technique using cyclodextrin or a derivative thereof has been developed. JP-A-58-58139 discloses a technique in which cyclodextrin is used in combination with an oil-soluble surfactant and emulsified by a specific method. JP-A-63-194726 discloses a technique using methylated β-cyclodextrin as an emulsifying aid.
しかしながら、これらの技術では従来の界面活性剤を
併用しているので皮膚刺激等の問題は完全には解決され
ていない。However, these techniques use a conventional surfactant in combination, so that problems such as skin irritation have not been completely solved.
本発明者ら従来の界面活性剤を全く用いない乳化化粧
料を得るべく研究の結果、シクロデキストリンの誘導体
の内で特にHACDを乳化剤として用いた場合において上記
の問題点を解決できることを見出し、本発明を完成し
た。The present inventors have conducted research to obtain a conventional emulsified cosmetic that does not use a surfactant at all, and as a result, have found that among the derivatives of cyclodextrin, the above problem can be solved particularly when HACD is used as an emulsifier. Completed the invention.
[課題を解決するための手段] すなわち本発明は、ヒドロキシアルキル化シクロデキ
ストリンと水と油を含有し、シクロデキストリンポリマ
ーおよびレシチンをいずれも配合せず、かつ油をヒドロ
キシアルキル化シクロデキストリンに対して等量(重量
比)以上配合することを特徴とする乳化化粧料に関する
ものである。[Means for Solving the Problems] That is, the present invention comprises a hydroxyalkylated cyclodextrin, water and an oil, does not contain any cyclodextrin polymer and lecithin, and converts the oil to the hydroxyalkylated cyclodextrin. The present invention relates to an emulsified cosmetic characterized by being blended in an equal amount (weight ratio) or more.
以下に、本発明の構成について詳述する。 Hereinafter, the configuration of the present invention will be described in detail.
本発明に用いられるHACDは、従来から環状オリゴ糖と
してよく知られているシクロデキストリンの水酸基にヒ
ドロキシアルキル基を導入したものである。The HACD used in the present invention is obtained by introducing a hydroxyalkyl group into a hydroxyl group of cyclodextrin, which is conventionally well known as a cyclic oligosaccharide.
ヒドロキシアルキルとしては、主にヒドロキシメチ
ル、ヒドロキシエチル、ヒドロキシプロピル、などの置
換基が使用され、これら置換反応の結果、ヒドロキシメ
チルシクロデキストリン、ヒドロキシエチルシクロデキ
ストリン、ヒドロキシプロピルシクロデキストリン、ヒ
ドロキシブチルシクロデキストリン、ジヒドロキシプロ
ピルシクロデキストリンなどのHACDを得ることができ
る。As the hydroxyalkyl, substituents such as hydroxymethyl, hydroxyethyl, and hydroxypropyl are mainly used.As a result of these substitution reactions, hydroxymethylcyclodextrin, hydroxyethylcyclodextrin, hydroxypropylcyclodextrin, hydroxybutylcyclodextrin, An HACD such as dihydroxypropylcyclodextrin can be obtained.
ヒドロキシアルキル基の置換度は1〜14が好ましい。 The substitution degree of the hydroxyalkyl group is preferably from 1 to 14.
シクロデキストリン(以下、CDと略する)は、グルコ
ースの数の違いによってα、β、γの構造をもつCD(以
下、α−CD、β−CD、γ−CDと略する。)が知られてい
るが、本発明はこれらのCDの一種または2種以上をヒド
ロキシアルキル化して使用する。普通はβ−CDを用いる
が、α、γ−CDを母核としてもかまわない。α、β、γ
のCDの同時に含有する澱粉分解物も使用できる。Cyclodextrin (hereinafter abbreviated as CD) is known to have a structure of α, β, and γ (hereinafter abbreviated as α-CD, β-CD, and γ-CD) depending on the number of glucoses. However, the present invention uses one or more of these CDs after hydroxyalkylation. Usually, β-CD is used, but α, γ-CD may be used as a mother nucleus. α, β, γ
And a starch hydrolyzate containing the same CD simultaneously.
これらHACDのうち、価格、製造のしやすさ使用性、水
溶解性を考慮した場合、ヒドロキシエチル化β−CDまた
はヒドロキシプロピル化β−CDが好ましいが、これに限
定されるものではない。また、ヒドロキシエチル化CDま
たはヒドロキシプロピル化CDは製造状態においてはα、
β、γが混じりあった混合物となっているが、混合物の
ままでもα、β、γのヒドロキシプロピル化CDを単離し
たものでも使用することができる。Among these HACDs, hydroxyethylated β-CD or hydroxypropylated β-CD is preferable in consideration of price, ease of production, usability, and water solubility, but is not limited thereto. In addition, hydroxyethylated CD or hydroxypropylated CD is α,
Although the mixture is a mixture of β and γ, it is possible to use the mixture as it is, or to isolate the hydroxypropylated CD of α, β, and γ.
HACDの製造方法としては、従来からいくつかの方法が
知られているが、以下に一例を示す。As a method for producing HACD, several methods have been conventionally known, and an example is shown below.
β−CD(日本食品化工製、商標名:セルデックスN)
100gを20%NaOH水溶液150mlに溶解し、30°Cに保持し
つつ酸化プロピレン50mlを徐々に滴下し、20時間攪拌し
反応を続ける。反応終了後、塩酸でpH6.0に中和し、透
析膜チューブ中に入れ、流水下24時間脱塩を行なった。
その後凍結乾燥機で乾燥を行なって、ヒドロキシプロピ
ル化β−CD約90gが得られた。このヒドロキシプロピル
化β−CDのCD当たりの置換度は5.1であった。β-CD (Nippon Shokuhin Kako, brand name: Celldex N)
100 g was dissolved in 150 ml of a 20% aqueous NaOH solution, and while maintaining the temperature at 30 ° C., 50 ml of propylene oxide was gradually added dropwise, followed by stirring for 20 hours to continue the reaction. After completion of the reaction, the mixture was neutralized to pH 6.0 with hydrochloric acid, placed in a dialysis membrane tube, and desalted under running water for 24 hours.
Thereafter, drying was performed with a freeze dryer to obtain about 90 g of hydroxypropylated β-CD. The substitution degree per CD of this hydroxypropylated β-CD was 5.1.
本発明の乳化化粧料に用いられる油としては、例えば
マカデミアナッツ油、月見草油、オリーブ油、ミンク
油、ホホバ油、ラノリン、スクワレン等の天然動植物油
脂類、流動パラフィン、パラフィンワックス、スクワラ
ン等の炭化水素類、鯨ロウ、密ロウ、キャンデリラワッ
クス、カルナウバロウ等のワックス類、セタノール、イ
ソセタノール、ステアリルアルコール、イソステアリル
アルコール等の高級アルコール類、ミリスチン酸、パル
ミチン酸、ステアリン酸、ベヘニン酸、イソステアリン
酸等の高級脂肪酸類、イソプロピルミリスチン酸、イソ
プロピルパルミチン酸、イソプロピルイソステアリン
酸、2エチルヘキサン酸グリセリール等のエステル類、
その他ジエチレングリールモノプロピレンペンタエリリ
トールエーテル、リノール酸エチル、ポリオキシプロピ
レンブチルエーテル等の極性オイルやシリコーン油等を
挙げることができる。Examples of the oil used in the emulsified cosmetic of the present invention include natural animal and vegetable oils and fats such as macadamia nut oil, evening primrose oil, olive oil, mink oil, jojoba oil, lanolin and squalene, and liquid hydrocarbons such as paraffin, paraffin wax and squalane. , Waxes such as whale wax, beeswax, candelilla wax, carnauba wax, higher alcohols such as cetanol, isocetanol, stearyl alcohol, isostearyl alcohol, myristic acid, palmitic acid, stearic acid, behenic acid, isostearic acid, etc. Esters such as higher fatty acids, isopropyl myristate, isopropyl palmitate, isopropyl isostearate, and glyceryl 2-ethylhexanoate;
Other examples include polar oils such as diethylene glycol monopropylene pentaerythritol ether, ethyl linoleate, and polyoxypropylene butyl ether, and silicone oils.
本発明の乳化化粧料は、乳化剤としてHACDを用いる以
外は常法に従って、油、及び水等を配合して乳化せしめ
ることにより調製される。そしてこの乳化型は水中油型
及び油中水型のいずれであってもよい。The emulsified cosmetic of the present invention is prepared by blending oil and water and emulsifying according to a conventional method except that HACD is used as an emulsifier. The emulsion type may be any of an oil-in-water type and a water-in-oil type.
本発明の乳化化粧料の好ましい組成は、次の通りであ
る。The preferred composition of the emulsified cosmetic of the present invention is as follows.
配合量(重量%)好ましい量(重量%) 油 1〜60 5〜35 HACD 2〜10 3〜5 水 25〜95 40〜90 また、本発明の乳化化粧料には本発明の効果を損なわ
ない範囲で更に各種任意成分を配合することができ、例
えばD−マンニット、乳糖などの可溶性粉末基材、グリ
セリン、ヒアルロン酸などの保湿剤、ビタミンC、ビタ
ミンEなどの薬剤、消炎剤、紫外線吸収剤、酸化防止
剤、防腐剤、粘度調整剤、色素類、生薬類、香料成分等
が挙げられる。Blending amount (% by weight) Preferred amount (% by weight) Oil 1 to 60 5 to 35 HACD 2 to 10 3 to 5 Water 25 to 95 40 to 90 The emulsified cosmetic of the present invention does not impair the effects of the present invention. Various optional components can be further blended within the range, for example, soluble powder bases such as D-mannitol and lactose, humectants such as glycerin and hyaluronic acid, drugs such as vitamin C and vitamin E, anti-inflammatory agents, ultraviolet absorption Agents, antioxidants, preservatives, viscosity modifiers, pigments, crude drugs, fragrance components and the like.
本発明の乳化化粧料は種々の用途に併せた形態、例え
ばバニシングクリーム、乳液、コールドクリーム、クレ
ンジングクリーム、ファンデーションクリーム、ハンド
クリーム、外用軟膏等の形態とすることができる。The emulsified cosmetic of the present invention can be in a form suitable for various uses, such as a vanishing cream, a milky lotion, a cold cream, a cleansing cream, a foundation cream, a hand cream, an external ointment, and the like.
[実施例] 次に実施例を挙げて説明するが、本発明はこれらの実
施例に制限されるものではない。[Examples] Next, examples will be described, but the present invention is not limited to these examples.
実施例1 コールドクリーム A油性成分ワセリン 3 ミツロウ 2 セタノール 2.5 ラノリン 5 スクワラン 20 流動パラフィン 10 B香料 0.5 C防腐剤 適量 D酸化防止剤 適量 E乳化剤 ヒドロキシプロピル化β−CD 3.9 F水相 精製水 残余 プロピレングリコール 5 FにEを70°Cで加熱、溶解し水相部とし、A,B,C,D
を70°Cに加熱し、混合溶解して油相部とする。水相部
を攪拌しながら油相部を徐々に添加、分散して乳化す
る。乳化物を熱交換機を用いて冷却してコールドクリー
ムを得る。Example 1 Cold Cream A Oily Component Vaseline 3 Beeswax 2 Cetanol 2.5 Lanolin 5 Squalane 20 Liquid Paraffin 10 B Fragrance 0.5 C Preservatives Appropriate D Antioxidant Appropriate E Emulsifier Hydroxypropylated β-CD 3.9 F Water Phase Purified Water Residue Propylene Glycol Heat and dissolve E in 5 F at 70 ° C to make the aqueous phase, and then add A, B, C, D
Is heated to 70 ° C. and mixed and dissolved to form an oil phase. While stirring the aqueous phase, the oil phase is gradually added, dispersed and emulsified. The emulsion is cooled using a heat exchanger to obtain a cold cream.
比較例1 コールドクリーム A油性成分ワセリン 3 ミツロウ 2 セタノール 2.5 ラノリン 5 スクワラン 20 流動パラフィン 10 B香料 0.5 C防腐剤 適量 D酸化防止剤 適量 E乳化剤・乳化補助剤 ソルビタンモノステアリン酸エステル(HLB4.7) 2.2 ポリオキシエチレン(20モル)ソルビタンモノステ
アリン酸エステル(HLB14.9) 1.2 メチル化β−CD 0.5 F水相 精製水 残余 プロピレングリコール 5 実施例1と同様にしてコールドクリームを得る。Comparative Example 1 Cold Cream A Oily Component Vaseline 3 Beeswax 2 Cetanol 2.5 Lanolin 5 Squalane 20 Liquid Paraffin 10 B Flavor 0.5 C Preservatives Appropriate D Antioxidant Appropriate E Emulsifier / Emulsifier Sorbitan Monostearate (HLB4.7) 2.2 Polyoxyethylene (20 mol) sorbitan monostearate (HLB14.9) 1.2 Methylated β-CD 0.5 F aqueous phase Purified water Residue Propylene glycol 5 A cold cream is obtained in the same manner as in Example 1.
比較例2 コールドクリーム A油性成分ワセリン 3 ミツロウ 2 セタノール 2.5 ラノリン 5 スクワラン 20 流動パラフィン 10 B香料 0.5 C防腐剤 適量 D酸化防止剤 適量 E乳化剤 β−CD 3.9 F水相 精製水 残余 プロピレングリコール 5 実施例1と同様にしてコールドクリームを得る。Comparative Example 2 Cold Cream A Oily Component Vaseline 3 Beeswax 2 Cetanol 2.5 Lanolin 5 Squalane 20 Liquid Paraffin 10 B Flavor 0.5 C Preservatives Appropriate D Antioxidant Appropriate E Emulsifier β-CD 3.9 F Water Phase Purified Water Residue Propylene Glycol 5 Example A cold cream is obtained in the same manner as in 1.
実施例1及び比較例1,2の乳化安定性と皮膚刺激性の
評価を下記の基準により行ない、結果を表1に示した。The emulsion stability and skin irritation of Example 1 and Comparative Examples 1 and 2 were evaluated according to the following criteria, and the results are shown in Table 1.
乳化安定性 実施例1及び比較例1,2のコールドクリームを50°C
の恒温槽に1週間放置後、状態を観察した。Emulsion stability The cold creams of Example 1 and Comparative Examples 1 and 2 were heated at 50 ° C.
After standing in a constant temperature bath for 1 week, the state was observed.
○・・・状態に全く変化なし △・・・油相と水相の分離がわずかにみられる ×・・・油相と水相がかなり分離している 皮膚刺激性 実施例1及び比較例1,2のコールドクリームをそれぞ
れ50名のパネルの上腕に塗布し、24時間後の皮膚の様子
を観察、皮膚に赤み等の発生したパネルの人数を調べ
た。○: no change in state △: slight separation of oil phase and aqueous phase ×: considerable separation of oil phase and aqueous phase Skin irritation Example 1 and Comparative Example 1 , 2 cold creams were applied to the upper arm of each of 50 panels, the appearance of the skin 24 hours later was observed, and the number of panels with reddishness on the skin was examined.
実施例2 バニシングクリーム Aステアリン酸 10 ステアリルアルコール 4 ステアリン酸ブチル 8 B香料 0.1 C防腐剤 適量 D酸化防止剤 適量 Eヒドロキシプロピル化β−CD 5 Fプロピレングリコール 3 グリセリン 4 精製水 残余 実施例1と同様にしてバニシングクリームを得る。 Example 2 Vanishing Cream A Stearate 10 Stearyl Alcohol 4 Butyl Stearate 8 B Fragrance 0.1 C Preservatives Adequate D Antioxidant Adequate E Hydroxypropylated β-CD 5 F Propylene Glycol 3 Glycerin 4 Purified Water Residue Same as Example 1 To get a burnishing cream.
実施例3 クレンジングクリーム A流動パラフィン 40 ワセリン 10 ミツロウ 6 パラフィン 2 B香料 0.1 C防腐剤 適量 Eヒドロキシエチル化β−CD 7 F精製水 残余 実施例1と同様にしてクレンジングクリームを得る。Example 3 Cleansing Cream A Liquid Paraffin 40 Vaseline 10 Beeswax 6 Paraffin 2 B Fragrance 0.1 C Preservative Appropriate amount E Hydroxyethylated β-CD 7 F Purified Water Residue A cleansing cream is obtained in the same manner as in Example 1.
実施例4 乳液 A流動パラフィン 7 ラノリン 3 オレイン酸 3 B香料 0.1 C防腐剤 適量 Eヒドロキシプロピル化β−CD 3 Fビーガム 1 グリセリン 3 精製水 残余 実施例1と同様にして乳液を得る。Example 4 Emulsion A Liquid paraffin 7 Lanolin 3 Oleic acid 3 B fragrance 0.1 C Preservative Appropriate amount E Hydroxypropylated β-CD 3 F Vegum 1 Glycerin 3 Purified water Residue The same procedure as in Example 1 is used to obtain an emulsion.
実施例5 外用軟膏 A流動パラフィン 10 スクワラン 15 ラノリン 5 消炎剤 3 C防腐剤 適量 D酸化防止剤 適量 Eヒドロキシプロピル化β−CD 3 α、β、γ−CD混合物 7 Fグリセリン 3 オリゴ糖 3 精製水 残余 実施例1と同様にして外用軟膏を得る。Example 5 Ointment for external use A Liquid paraffin 10 Squalane 15 Lanolin 5 Antiphlogistic agent 3 C Preservative proper amount D Antioxidant proper amount E Hydroxypropylated β-CD3 α, β, γ-CD mixture 7 F glycerin 3 oligosaccharide 3 Purified water Residual An ointment for external use is obtained in the same manner as in Example 1.
実施例6 ファンデーションクリーム Aステアリン酸 2.5 セトステアリルアルコール 2 液状ラノリン 2 流動パラフィン 3 ホホバ油 2 ミリスチン酸イソプロピル 8 B酸化防止剤 適量 C防腐剤 適量 D香料 0.2 E酸化チタン 8 タルク 4 着色顔料 適量 Fカルボキシメチルセルロースナトリウム 0.2 ベントナイト 0.5 プロピレングリコール 5 精製水 残余 Gヒドロキシプロピルα−CD 10 AにB,C,Dを加熱溶解し、Eを混合、分散して油相部と
する。FにGを溶解させて水相部とする。油相部を70°
Cに加熱し、攪拌し、水相部を徐々に添加して分散、乳
化する。熱交換機を用いて冷却してファンデーションを
得る。Example 6 Foundation cream A Stearic acid 2.5 Cetostearyl alcohol 2 Liquid lanolin 2 Liquid paraffin 3 Jojoba oil 2 Isopropyl myristate 8 B Antioxidant proper amount C preservative proper amount D flavor 0.2 E titanium oxide 8 talc 4 Color pigment proper amount F carboxymethylcellulose Sodium 0.2 Bentonite 0.5 Propylene glycol 5 Purified water Residual B, C, D are dissolved in G hydroxypropyl α-CD 10 A by heating, and E is mixed and dispersed to form an oil phase. G is dissolved in F to form an aqueous phase. 70 ° oil phase
C. The mixture is heated and stirred, and the aqueous phase is gradually added to disperse and emulsify. Cool using a heat exchanger to obtain a foundation.
以上、上記の各実施例は皮膚への刺激の懸念がなく、
保存安定性のよいものである。As described above, each of the above embodiments has no fear of irritation to the skin,
It has good storage stability.
[発明の効果] 本発明の乳化化粧料は、従来の界面活性剤を用いるこ
となく良好な安定性が得られ、皮膚刺激の懸念がなく、
保湿効果の高い特性を有する。[Effects of the Invention] The emulsified cosmetic of the present invention can obtain good stability without using a conventional surfactant, and has no fear of skin irritation.
It has high moisturizing properties.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 6 , DB name) A61K 7/00
Claims (1)
と水と油を含有し、シクロデキストリンポリマーおよび
レシチンをいずれも配合せず、かつ油をヒドロキシアル
キル化シクロデキストリンに対して等量(重量比)以上
配合することを特徴とする乳化化粧料。1. A composition containing a hydroxyalkylated cyclodextrin, water and an oil, containing neither a cyclodextrin polymer nor lecithin, and blending an oil in an equal amount (weight ratio) with respect to the hydroxyalkylated cyclodextrin. An emulsified cosmetic, characterized in that:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8690090A JP2941880B2 (en) | 1990-03-30 | 1990-03-30 | Emulsified cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8690090A JP2941880B2 (en) | 1990-03-30 | 1990-03-30 | Emulsified cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03284611A JPH03284611A (en) | 1991-12-16 |
JP2941880B2 true JP2941880B2 (en) | 1999-08-30 |
Family
ID=13899712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8690090A Expired - Lifetime JP2941880B2 (en) | 1990-03-30 | 1990-03-30 | Emulsified cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2941880B2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69636978T2 (en) | 1995-06-29 | 2007-09-06 | Shiseido Co. Ltd. | Aqueous composition containing a cholesterol ester clathrate, this containing cosme- ticum and method for its preparation |
JPH09208423A (en) * | 1995-11-30 | 1997-08-12 | Shiseido Co Ltd | Hydrating composition, cosmetics containing the same, and method for producing the same |
DE10239647A1 (en) * | 2002-08-29 | 2004-03-11 | Beiersdorf Ag | Cosmetic and/or dermatological oil/water emulsion, useful as cleanser and care formulation for skin, hair and nails, contains aqueous phase, unpolar to medium polar oil and cyclodextrin derivative |
JP4781680B2 (en) * | 2005-01-17 | 2011-09-28 | 株式会社Adeka | Preservative composition |
DE102006031500A1 (en) * | 2006-07-06 | 2008-04-17 | Henkel Kgaa | O / W emulsion |
CN105050567B (en) | 2013-04-05 | 2018-04-27 | 宝洁公司 | Include the personal care composition of pre-emulsified preparation |
WO2016093089A1 (en) * | 2014-12-12 | 2016-06-16 | ライオン株式会社 | Skin cleanser composition |
EP3405168B1 (en) | 2016-01-20 | 2025-01-22 | The Procter & Gamble Company | Hair conditioning composition comprising monoalkyl glyceryl ether |
-
1990
- 1990-03-30 JP JP8690090A patent/JP2941880B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH03284611A (en) | 1991-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0159271B1 (en) | Cosmetics containing inclusion product with hydroxyalkylated cyclodextrin and powder cosmetics thereof | |
EP0689829B1 (en) | Cosmetic compositions containing amino-multicarboxylate modified starch | |
JPH1067639A (en) | Vitamin E-Vitamin C phosphoric acid diester / cyclodextrin clathrate and external skin preparation containing the clathrate | |
EP2598207A2 (en) | Surfactant-free oil-in-water type emulsion, process for preparation and uses thereof | |
JP2941880B2 (en) | Emulsified cosmetic | |
JPH0662385B2 (en) | Emulsified composition | |
JP2944258B2 (en) | Emulsion type cosmetic | |
JPS63301826A (en) | Drug for external use | |
JP2916689B2 (en) | Cosmetics | |
JP3105345B2 (en) | Cosmetics | |
JPH09100225A (en) | Skin preparation for external use | |
JPS6138166B2 (en) | ||
JP2929108B2 (en) | Cosmetics and powder cosmetics | |
JPH1017434A (en) | Hydrate composition, cosmetic material and composition for lipstick compounded with the same and its production | |
JP3912722B2 (en) | Topical skin preparation | |
JP3004675B2 (en) | External preparation for skin | |
JP2938120B2 (en) | External preparation for skin | |
JP3481775B2 (en) | Microemulsions and cosmetics containing them | |
JP3648330B2 (en) | Method for producing cosmetic and method for producing lipstick composition | |
JP2001089353A (en) | Moisture-retaining composition, and composition for external use, containing the same | |
JPS63194726A (en) | emulsifying composition | |
JP2002087928A (en) | Moisturizers and cosmetics for cosmetics | |
JP3324927B2 (en) | Emulsion composition | |
JPH11244688A (en) | Oil in water emulsion composition | |
JP3351954B2 (en) | Emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090618 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20100618 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100618 Year of fee payment: 11 |